bullish
FSS Vs. Samsung BioLogics - Latest Situation Update
189 Views10 May 2018 04:38
Below is how the Samsung BioLogics accounting fraud case will be reviewed and concluded by the FSC. The FSS (Financial Supervisory Service) tables...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Last Week in Event SPACE: Samsung, Hyundai, Sirtex, BWX, Genting27 May 2018
- FSC Chairman Speaks on Decision Framework25 May 2018
- Last Week in Event SPACE: Samsung Biologics, Shire, Lotte, Mitula, JSW, Nisshinbo13 May 2018
- FSS Vs. Samsung BioLogics - Latest Situation Update10 May 2018
- Samsung BioLogics - Market Sentiment Assessment05 May 2018
- Samsung BioLogics and Biogen: Who Had Control?04 May 2018
- Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas01 May 2018
x